Previous Close | 11.81 |
Open | 11.47 |
Bid | 11.71 x 0 |
Ask | 11.73 x 0 |
Day's Range | 11.64 - 11.89 |
52 Week Range | 9.05 - 16.57 |
Volume | |
Avg. Volume | 6,367,158 |
Market Cap | 2.419B |
Beta (5Y Monthly) | 0.48 |
PE Ratio (TTM) | 16.97 |
EPS (TTM) | 0.69 |
Earnings Date | N/A |
Forward Dividend & Yield | 0.11 (0.94%) |
Ex-Dividend Date | Jul 04, 2023 |
1y Target Est | N/A |
Geron's (GERN) shares rise on approval of its first drug. The FDA approves imetelstat for the treatment of adult patients with lower-risk MDS with transfusion-dependent anemia.
Exact Sciences (EXAS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
(Updated - June 7, 2024 11:18 AM EDT)